Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 326

  • The following term was not found in PubMed: Athikkal.
1.

SUBCLINICAL MACULAR CHANGES AND DISEASE LATERALITY IN PEDIATRIC COATS DISEASE DETERMINED BY QUANTITATIVE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Schwartz R, Sivaprasad S, Macphee R, Ibanez P, Keane PA, Michaelides M, Wong SC.

Retina. 2018 Sep 17. doi: 10.1097/IAE.0000000000002322. [Epub ahead of print]

PMID:
30234852
2.

Clinical efficacy of eplerenone versus placebo for central serous chorioretinopathy: study protocol for the VICI randomised controlled trial.

Willcox A, Culliford L, Ellis L, Rogers CA, Cree A, Chakravarthy U, Ennis S, Behar-Cohen F, Reeves BC, Sivaprasad S, Lotery A.

Eye (Lond). 2018 Sep 7. doi: 10.1038/s41433-018-0212-2. [Epub ahead of print]

PMID:
30194380
3.

Molecular characterization of Nosema bombycis methionine aminopeptidase 2 (MetAP2) gene and evaluation of anti-microsporidian activity of Fumagilin-B in silkworm Bombyx mori.

Esvaran VG, Gupta T, Nayaka ARN, Sivaprasad V, Ponnuvel KM.

3 Biotech. 2018 Sep;8(9):386. doi: 10.1007/s13205-018-1411-z. Epub 2018 Aug 24.

PMID:
30175023
4.

Localization of Paracentral Acute Middle Maculopathy Using Optical Coherence Tomography Angiography.

Schwartz R, Hykin P, Sivaprasad S.

Ophthalmic Surg Lasers Imaging Retina. 2018 Aug 1;49(8):619-624. doi: 10.3928/23258160-20180803-10.

PMID:
30114307
5.

Normative Data on Foveal Avascular Zone Dimensions in Four Macular Vascular Layers.

Schwartz R, Bagchi A, Dubis A, Hykin P, Sivaprasad S.

Ophthalmic Surg Lasers Imaging Retina. 2018 Aug 1;49(8):580-586. doi: 10.3928/23258160-20180803-05.

PMID:
30114302
6.

Discrepancy in current central serous chorioretinopathy classification.

Singh SR, Matet A, van Dijk EHC, Daruich A, Fauser S, Yzer S, Peiretti E, Sivaprasad S, Lotery AJ, Boon CJF, Behar-Cohen F, Freund KB, Chhablani J.

Br J Ophthalmol. 2018 Jul 12. pii: bjophthalmol-2018-312435. doi: 10.1136/bjophthalmol-2018-312435. [Epub ahead of print]

PMID:
30002069
7.

Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting.

Eleftheriadou M, Gemenetzi M, Lukic M, Sivaprasad S, Hykin PG, Hamilton RD, Rajendram R, Tufail A, Patel PJ.

Ophthalmol Ther. 2018 Jul 7. doi: 10.1007/s40123-018-0139-5. [Epub ahead of print]

PMID:
29982914
8.

Monitoring and assessment of groundwater quality in a khondalitic terrain, Andhra Pradesh, India.

Prasad YS, Rao BV.

Environ Monit Assess. 2018 Jun 26;190(7):426. doi: 10.1007/s10661-018-6757-5.

PMID:
29946916
9.

Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.

Abdel-Hay A, Sivaprasad S, Subramanian A, Barbur JL.

PLoS One. 2018 Jun 26;13(6):e0199693. doi: 10.1371/journal.pone.0199693. eCollection 2018.

10.

Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes.

Chatziralli I, Regan SO, Mohamed R, Talks J, Sivaprasad S; UK Aflibercept Users Group.

Eye (Lond). 2018 Sep;32(9):1523-1529. doi: 10.1038/s41433-018-0114-3. Epub 2018 Jun 4.

PMID:
29867156
11.

Influence of Boron Nitride Nanosheets on the Crystallization and Polymorphism of Poly(l-lactide).

Rosely CVS, Nagendra B, Sivaprasad VP, Gowd EB.

J Phys Chem B. 2018 Jun 21;122(24):6442-6451. doi: 10.1021/acs.jpcb.8b03211. Epub 2018 Jun 7.

PMID:
29842779
12.

Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error.

Tedja MS, Wojciechowski R, Hysi PG, Eriksson N, Furlotte NA, Verhoeven VJM, Iglesias AI, Meester-Smoor MA, Tompson SW, Fan Q, Khawaja AP, Cheng CY, Höhn R, Yamashiro K, Wenocur A, Grazal C, Haller T, Metspalu A, Wedenoja J, Jonas JB, Wang YX, Xie J, Mitchell P, Foster PJ, Klein BEK, Klein R, Paterson AD, Hosseini SM, Shah RL, Williams C, Teo YY, Tham YC, Gupta P, Zhao W, Shi Y, Saw WY, Tai ES, Sim XL, Huffman JE, Polašek O, Hayward C, Bencic G, Rudan I, Wilson JF; CREAM Consortium; 23andMe Research Team; UK Biobank Eye and Vision Consortium, Joshi PK, Tsujikawa A, Matsuda F, Whisenhunt KN, Zeller T, van der Spek PJ, Haak R, Meijers-Heijboer H, van Leeuwen EM, Iyengar SK, Lass JH, Hofman A, Rivadeneira F, Uitterlinden AG, Vingerling JR, Lehtimäki T, Raitakari OT, Biino G, Concas MP, Schwantes-An TH, Igo RP Jr, Cuellar-Partida G, Martin NG, Craig JE, Gharahkhani P, Williams KM, Nag A, Rahi JS, Cumberland PM, Delcourt C, Bellenguez C, Ried JS, Bergen AA, Meitinger T, Gieger C, Wong TY, Hewitt AW, Mackey DA, Simpson CL, Pfeiffer N, Pärssinen O, Baird PN, Vitart V, Amin N, van Duijn CM, Bailey-Wilson JE, Young TL, Saw SM, Stambolian D, MacGregor S, Guggenheim JA, Tung JY, Hammond CJ, Klaver CCW.

Nat Genet. 2018 Jun;50(6):834-848. doi: 10.1038/s41588-018-0127-7. Epub 2018 May 28.

PMID:
29808027
13.

Vision Preference Value Scale and Patient Preferences in Choosing Therapy for Symptomatic Vitreomacular Interface Abnormality.

Linz MO, Bressler NM, Chaikitmongkol V, Sivaprasad S, Patikulsila D, Choovuthayakorn J, Watanachai N, Kunavisarut P, Menon D, Tadarati M, Delalíbera Pacheco K, Sanyal A, Scott AW.

JAMA Ophthalmol. 2018 Jun 1;136(6):658-664. doi: 10.1001/jamaophthalmol.2018.1272.

PMID:
29800983
14.

The past is the prologue to the future.

Sivaprasad S.

Eye (Lond). 2018 May;32(5):847-848. doi: 10.1038/s41433-018-0087-2. Epub 2018 May 8. No abstract available.

PMID:
29743624
15.

A new set of mulberry-specific SSR markers for application in cultivar identification and DUS testing.

Pinto MV, Poornima HS, Sivaprasad V, Girish Naik V.

J Genet. 2018 Apr 13;97(1):e31-e37. No abstract available.

16.

A noninterventional study to monitor patients with diabetic macular oedema starting treatment with ranibizumab (POLARIS).

Stefanickova J, Cunha-Vaz J, Ulbig M, Pearce I, Fernández-Vega Sanz A, Theodossiadis P, Kodjikian L, Izmailov A, Muston D, Vassilev Z, Lamotte B, Tückmantel C, Friedl S, Altemark A, Schwarz HJ, Katz T; POLARIS study investigators.

Acta Ophthalmol. 2018 Apr 25. doi: 10.1111/aos.13771. [Epub ahead of print]

PMID:
29696809
17.

Evolution of fundus autofluorescence patterns over time in patients with chronic central serous chorioretinopathy.

Zola M, Chatziralli I, Menon D, Schwartz R, Hykin P, Sivaprasad S.

Acta Ophthalmol. 2018 Apr 15. doi: 10.1111/aos.13742. [Epub ahead of print]

PMID:
29656602
18.

Reliability and Construct Validity of the NEI VFQ-25 in a Subset of Patients With Geographic Atrophy From the Phase 2 Mahalo Study.

Sivaprasad S, Tschosik E, Kapre A, Varma R, Bressler NM, Kimel M, Dolan C, Silverman D.

Am J Ophthalmol. 2018 Jun;190:1-8. doi: 10.1016/j.ajo.2018.03.006. Epub 2018 Mar 10.

19.

Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial.

Sivaprasad S, Vasconcelos JC, Prevost AT, Holmes H, Hykin P, George S, Murphy C, Kelly J, Arden GB; CLEOPATRA Study Group.

Lancet Diabetes Endocrinol. 2018 May;6(5):382-391. doi: 10.1016/S2213-8587(18)30036-6. Epub 2018 Mar 5.

20.

Prevalence of diabetic retinopathy and visual impairment in patients with diabetes mellitus in Zambia through the implementation of a mobile diabetic retinopathy screening project in the Copperbelt province: a cross-sectional study.

Lewis AD, Hogg RE, Chandran M, Musonda L, North L, Chakravarthy U, Sivaprasad S, Menon G.

Eye (Lond). 2018 Jul;32(7):1201-1208. doi: 10.1038/s41433-018-0055-x. Epub 2018 Mar 5.

PMID:
29503450

Supplemental Content

Loading ...
Support Center